TIANJIN, China, Nov. 30, 2017 /PRNewswire/ -- Asymchem Laboratories (Tianjin) Co., Ltd.
Dr. Hao Hong, CEO and Chairman of the Board of Asymchem Group, responded by stating, "We are encouraged by the continued success of agency audits for the Dunhua manufacturing site, and remain committed to improve our quality programs to ensure continued compliance to meet the highest quality standards in the manufacture of API's".
Asymchem is a CMC CDMO with over 20 years' expertise in developing innovative and sustainable processes for development to commercial APIs and HPAPIs. Operating out of six state of the art facilities in China and proficient in a number of niche technologies, including biotransformation, flow chemistry, highly-potent compounds, asymmetric synthesis, high-pressure and low- temperature chemistry, Asymchem is the main partner of choice for the global pharmaceutical industry.
View original content:http://www.prnewswire.com/news-releases/asymchem-dunhua-manufacturing-facility-successfully-completes-korean-mfds-inspection-300564832.html
SOURCE Asymchem Laboratories (Tianjin) Co., Ltd.
Subscribe to our Free Newsletters!
A prosthetic heart valve is an artificial device surgically implanted into the heart to replace a ...
PUVA or photochemotherapy is used to treat several skin disorders with the help of UV light and the ...
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...View All